A Review on Newer Ocular Drug Delivery Systems with an Emphasis on Glaucoma

Maneesha Peter ¹ , Rajitha Panonnummal ¹ *

Cited by CrossRef: 6

1- Dludla S, Mashabela L, Ng’andwe B, Makoni P, Witika B. Current Advances in Nano-Based and Polymeric Stimuli-Responsive Drug Delivery Targeting the Ocular Microenvironment: A Review and Envisaged Future Perspectives. Polymers. 2022;14(17):3580 [Crossref]

2- Kaushal N, Kumar M, Singh A, Tiwari A, Tiwari V, Pahwa R. A Review on Polymeric Nanostructured Micelles for the Ocular Inflammation-Main Emphasis on Uveitis. PNT. 2023;11(1):34 [Crossref]

3- Ali F, Al-Shohani A. Preparation and Evaluation of in situ Ophthalmic Gel with a Dual Triggered Mechanism for the Delivery of Gatifloxacin and Betamethasone . Al-Rafidain J Med Sci. 2024;6(2):56 [Crossref]

4- Iqbal H, Razzaq A, Zhou D, Lou J, Xiao R, Lin F, Liang Y. Nanomedicine in glaucoma treatment; Current challenges and future perspectives. Materials Today Bio. 2024;28:101229 [Crossref]

5- M K, Damodaran A, Joseph S, Kumar V, Pillai G, Nair S. Vitreoretinal Disease: a Critical Review on Current Technological Perspectives and Innovative drug-delivery Strategies. Ther Deliv. 2023;14(5):337 [Crossref]

6- Hovanesian J, Singh I, Bauskar A, Vantipalli S, Ozden R, Goldstein M. Identifying and addressing common contributors to nonadherence with ophthalmic medical therapy. 2023;34(Supplement 1):S1 [Crossref]